HXPLF(HXPLF)
HXPLF
No analyst ratings available
No analyst price targets available for HXPLF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $19.89B | $21.08B | $21.82B | $21.65B | $21.86B |
| Low | $19.64B | $18.54B | $20.34B | $20.18B | $20.38B |
| High | $20.03B | $22.65B | $22.72B | $22.54B | $22.77B |
| EBITDA Avg | $3.75B | $3.97B | $4.11B | $4.08B | $4.12B |
| Low | $3.70B | $3.49B | $3.83B | $3.80B | $3.84B |
| High | $3.77B | $4.26B | $4.28B | $4.24B | $4.29B |
| EBIT Avg | $3.21B | $3.40B | $3.52B | $3.49B | $3.53B |
| Low | $3.17B | $2.99B | $3.28B | $3.26B | $3.29B |
| High | $3.23B | $3.66B | $3.67B | $3.64B | $3.67B |
| Net Income Avg | $2.09B | $2.28B | $2.42B | $2.51B | $2.58B |
| Low | $1.91B | $2.08B | $2.21B | $2.29B | $2.35B |
| High | $2.20B | $2.40B | $2.55B | $2.64B | $2.71B |
| EPS Avg | $6.07 | $6.61 | $7.02 | $7.28 | $7.48 |
| Low | $5.53 | $6.03 | $6.40 | $6.64 | $6.82 |
| High | $6.39 | $6.97 | $7.40 | $7.67 | $7.88 |
| Analysts (Rev / EPS) | 5 / 1 | 6 / 1 | 2 / 1 | 4 / 1 | 3 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $5.13B | $4.65B |
| Low | $5.09B | $4.62B |
| High | $5.17B | $4.69B |
| EBITDA Avg | $965M | $876M |
| Low | $958M | $870M |
| High | $973M | $883M |
| EBIT Avg | $827M | $751M |
| Low | $821M | $746M |
| High | $834M | $757M |
| Net Income Avg | $540M | $499M |
| Low | $535M | $494M |
| High | $546M | $504M |
| EPS Avg | $1.57 | $1.45 |
| Low | $1.55 | $1.43 |
| High | $1.58 | $1.46 |
| Analysts (Rev / EPS) | 4 / 1 | 4 / 1 |